Target intelligence / Profile preview

Mitochondria and neuroprotective pathways

Molecular classification
Other
01

Overview

Mitochondria and neuroprotective pathways refer to the integrated biological systems that maintain mitochondrial integrity to protect neurons from injury and death (Lin & Beal, 2006). Mitochondria are central to cellular energy metabolism, calcium signaling, and the initiation of apoptosis, making them critical determinants of neuronal survival (Murphy & Hartley, 2018). Dysfunction in these pathways, characterized by oxidative stress and impaired ATP production, is a primary driver of neurodegenerative disorders such as Parkinson's and Alzheimer's disease (Bhatia et al., 2022). Therapeutic approaches targeting these pathways involve the use of antioxidants, mitochondrial membrane stabilizers, and metabolic enhancers like Elamipretide or MitoQ (ClinicalTrials.gov). While not a single molecular target, this category encompasses a variety of specific proteins and enzymes involved in mitochondrial quality control and bioenergetics. These pathways are essential for maintaining the high energy demands of neurons and preventing the release of pro-apoptotic factors like cytochrome c. Research in this area often focuses on the PGC-1alpha/SIRT1 axis to promote mitochondrial biogenesis as a neuroprotective strategy. Overall, modulating these pathways represents a significant frontier in treating chronic neurological conditions.

Other names
Mitochondrial neuroprotectionMitochondrial quality control pathwaysMitochondrial bioenergetic pathways
02

Mechanism of action

Enhancement of mitochondrial bioenergetics, reduction of reactive oxygen species (ROS) production, and stabilization of the mitochondrial membrane to prevent the activation of neuronal cell death cascades.

03

Biological functions

Energy metabolismApoptosisOxidative stress regulationCalcium homeostasisMitochondrial biogenesis
04

Disease associations

Neurodegenerative diseaseAlzheimer's diseaseParkinson's diseaseAmyotrophic lateral sclerosisHuntington's diseaseStroke
05

Safety considerations

Systemic metabolic interferencePoor blood-brain barrier permeabilityPotential for pro-oxidant effects at supra-therapeutic dosesOff-target effects on non-neuronal mitochondrial populations
06

Interacting drugs

Idebenone

5 more in the full profile.

07

Biomarkers

Lactate/pyruvate ratioMitochondrial DNA (mtDNA) copy number8-hydroxy-2-deoxyguanosine (8-OHdG)Cytochrome c releaseATP production rate

Beyond the preview

Go deeper on Mitochondria and neuroprotective pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondria and neuroprotective pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call